Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis: a Multicenter, Prospective, Randomized, Controlled Clinical Study

NCT05205603 is registered in ClinicalTrials.gov with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor.

NCT NCT05205603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05205603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis: a Multicenter, Prospective, Randomized, Controlled Clinical Study
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Phase 4
Overall status
Completed
Start date
January 15, 2022
Completion date
January 15, 2025
Enrollment
438 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

biologics, efficacy, self, mesalazine, ulcerative colitis